Bank of America’s iSpecimen ISPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2
Closed -$22 6306
2025
Q4
$22 Buy
2
+1
+100% +$25 ﹤0.01% 7105
2025
Q3
$58 Hold
1
﹤0.01% 7974
2025
Q2
$22 Buy
+1
New +$47 ﹤0.01% 8232
2025
Q1
Hold
0
8227
2024
Q4
Sell
-1
Closed -$167 8033
2024
Q3
$277 Buy
+1
New +$217 ﹤0.01% 7497
2024
Q2
Hold
0
8059
2023
Q1
Hold
0
-$16 8032
2022
Q4
Sell
-1
Closed -$1.22K 8017
2022
Q3
$2K Hold
1
﹤0.01% 7571
2022
Q2
$2K Buy
+1
New +$2.45K ﹤0.01% 7788
2022
Q1
Hold
0
8500
2021
Q4
Hold
0
8412

Other funds holding ISPC

Bank of America's ISPC Position: Q1 2026 in Review

Bank of America sold out of iSpecimen (ISPC) in Q1 2026, closing a stake of 2 shares — an estimated $22 sold.

Bank of America first reported a position in ISPC in Q2 2022 and held it in 6 quarters. The position peaked at $2K in Q3 2022. 9 funds tracked by Wall St. Rank hold ISPC as of Q1 2026.

  • Bank of America reported no remaining iSpecimen position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 2 iSpecimen shares in Q1 2026, an estimated $22.
  • Bank of America first reported a position in iSpecimen in Q2 2022 and held it in 6 quarters.
  • Bank of America's iSpecimen position peaked at $2K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held iSpecimen as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.